Morphine to Hydromorphone Conversion
Convert morphine 30mg PO Q4h to hydromorphone 6mg PO Q4h, then reduce by 25-50% to account for incomplete cross-tolerance, resulting in a starting dose of hydromorphone 3-4.5mg PO Q4h.
Conversion Calculation
Step 1: Calculate Total Daily Morphine Dose
Step 2: Apply Oral Morphine to Oral Hydromorphone Ratio
- The standard conversion ratio is 5:1 (oral morphine to oral hydromorphone) 2, 3, 4, 5
- Some sources suggest hydromorphone is 5-7 times more potent than morphine, but the 5:1 ratio is most consistently recommended across guidelines 2, 3
- Calculated hydromorphone dose = 180mg ÷ 5 = 36mg per day 4, 5
Step 3: Divide into Q4h Dosing
- 36mg per day ÷ 6 doses = 6mg Q4h 1
Step 4: Apply Incomplete Cross-Tolerance Reduction
- Reduce the calculated dose by 25-50% to account for incomplete cross-tolerance 2, 6
- This is a critical safety step when converting between opioids, even when pain is well-controlled 6
- Final starting dose range: 3-4.5mg PO Q4h 2, 6
Dosing Recommendations Based on Clinical Context
If Pain Was Well-Controlled on Morphine
- Start with 3mg PO Q4h (50% reduction) 6
- This conservative approach minimizes risk of oversedation while maintaining adequate analgesia 6
If Pain Was Poorly Controlled on Morphine
- Start with 4.5mg PO Q4h (25% reduction) or consider using the full calculated dose of 6mg 6
- The higher end of the range is appropriate when converting due to inadequate pain control 6
Breakthrough Dosing
- Prescribe immediate-release hydromorphone for breakthrough pain equal to 10-20% of the total 24-hour dose 2
- For a patient on 18-27mg per day, breakthrough doses should be 2-5mg 2
- Alternatively, the breakthrough dose can equal the regular 4-hourly dose (3-4.5mg in this case) 2
Special Population Adjustments
Renal Impairment
- Start with one-fourth to one-half the calculated dose 2, 6
- Hydromorphone is safer than morphine in renal failure, but active metabolites can still accumulate 2
- For a patient with renal impairment, start with 1.5-2.25mg PO Q4h 2
Hepatic Impairment
- Reduce the initial dose by 25-50% (one-fourth to one-half the usual dose) 2, 6
- Hydromorphone undergoes glucuronidation, which may be impaired in hepatic dysfunction 2
- Start with 1.5-3mg PO Q4h in hepatic impairment 2, 6
Mandatory Concurrent Prescriptions
Bowel Regimen
- Institute a stimulant laxative (senna) prophylactically in all patients receiving hydromorphone unless contraindicated 2, 6, 1
- Constipation is universal with opioid therapy and must be prevented, not just treated 6, 1
- Increase laxative dose when escalating opioid dose 1
Antiemetic Prophylaxis
- For patients with a history of opioid-induced nausea, prescribe prophylactic antiemetics 2
Monitoring and Titration
Initial Monitoring
- Reassess pain control and adverse effects within 24 hours after conversion 6
- Steady state is reached within 24 hours after dose adjustment 2, 6
Dose Titration Strategy
- If more than 3-4 breakthrough doses are required per day, increase the scheduled baseline dose by 25-50% rather than shortening the dosing interval 2, 6
- When pain returns consistently before the next dose, increase the dose rather than the frequency 2
- There is no advantage to dosing more frequently than Q4h for immediate-release hydromorphone 2
Critical Safety Considerations
Respiratory Depression
- Monitor oxygen saturation closely, particularly during initiation and after dose increases 2
- Have naloxone readily available; dilute in normal saline and administer every 30-60 seconds until improvement 2